Ajanta Pharma Ltd - Share Price Target 2026
(NSE: AJANTPHARM)
Sector: Healthcare
Market Cap: 35415.50 Cr
2862.73
-3470.00
Target Price Range
2700.00
-17.60 (-0.65%)
CMP
Bullish
As on 23 Jan 2026, 03:30 pm
Market Trends
Based on 5 research reports, 6 technical indicators and 1 trade calls on SEBI Registered Telegram Channels.
Bullish9
Bearish1
Neutral2
Agg. Profit Potential16.05%
Agg. Risk 11.46%
Last updated on: 23/01/2026, 3:30 pm
Returns
| Period | Return % |
|---|---|
| 1 Month | 4.58 |
| 3 Months | 4.44 |
| 1 Year | -8.68 |
| 5 Years | 155.09 |
Last updated on: 04/12/2025, 9:30 AM
Institutional Holdings
| Institute | Percentage | No. of Shares |
|---|---|---|
| Uti-Flexi Cap Fund | 3.41% | 4,263,828 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | 2.84% | 3,552,275 |
| Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110 | 1.85% | 2,311,816 |
| Canara Robeco Mutual Fund A/C Canara Robeco Large And Mid Cap Fund | 1.61% | 2,009,476 |
| Kotak Small Cap Fund | 1.43% | 1,789,568 |
Last updated on: 9/30/2025, 12:00:00 AM
Loading technical analysis...
Fundamental Data
Fundamental Analysis
P/E Ratio
37.26
P/B Ratio
8.58
PEG Ratio
2.46
ROE
26.09%
EPS
76.07
Dividend Yield
0.99%
Market Cap
35415.50 Cr
Sector
N/A
Last Updated: 8 Jan 2026, 02:30 pm
Peer Comparison
| Company | Sentiment | Target Price | Upside |
|---|---|---|---|
About : Ajanta Pharma Ltd.
Incorporated Year
1979
City and State
Mumbai, Maharashtra
Listing Date
Director's Name
Yogesh M Agrawal
Revenue
4481.34 Cr
Net Profit
916.89 Cr